Dr. Reddy’s, Prestige BioPharma ink pact on cancer drug
The Hindu
DRL gets rights to commercialise proposed trastuzumab biosimilar in select LatAm, S-E Asia markets.
Pharma major Dr. Reddy’s Laboratories has entered into a partnership with Prestige BioPharma under which it will get exclusive rights to supply and commercialise the Singapore firm’s proposed trastuzumab biosimilar in select Latin America and Southeast Asian countries.
Prestige BioPharma’s trastuzumab (HD201) is a proposed biosimilar to Roche’s Herceptin. It can be prescribed for treatment of HER2 positive breast and metastatic gastric cancer, the two companies said in a release on a binding agreement they have signed.
OpenAI unveiled a Stargate Community plan on Tuesday, aimed at “paying its way on energy” and ensuring that its operations do not raise electricity costs for local communities.
UFBU calls for a nationwide bank strike on January 27, demanding a five-day work week, affecting services for four consecutive days.
Jharkhand government and Tata Steel sign ₹11,000 crore MoU in Davos to boost green steel technologies and sustainable industrial growth.
Rupee hits record low of 91.28 against the U.S. dollar amid rising geopolitical tensions and sluggish market sentiment.
Stock markets decline as Sensex and Nifty drop amid geopolitical tensions and significant foreign fund outflows in early trade.
World Economic Forum 2026 The Hindu LIVE updates: Trump heads for Davos maelstrom over Greenland on January 21, 2026
Palantir leaders said the U.S. technology company has clinched a deal to sell more software to HD Hyundai, ramping up its heavy-industry work in South Korea.
Jio BlackRock AMC attracts 10 lakh investors, with 18% being first-time participants, focusing on B-30 cities and innovative funds.
Arohan Financial Services plans to hit capital market during middle of 2026-27 with ₹1,500 crore IPO
Arohan Financial Services plans a ₹1,500 crore IPO in 2026-27 to strengthen its capital base and expand services.
ITC Hotels reports a 9.6% Q3 net profit rise to ₹237 crore, driven by increased revenue and strategic expansions.
Gold reaches a record high of $4,700/oz as geopolitical tensions and safety demand drive unprecedented market growth.
Skoda Auto India aims for sustained growth with 10 new product launches planned for 2026, enhancing market reach and model upgrades.
Sensex and Nifty drop over 1% amid geopolitical tensions, heavy selling, and negative global cues affecting investor sentiment.